On the other hand, the results of FCM showed that the positive cell ratio of angiogenic biomarkers (CD31 or VEGFR2) in tumor tissue of Atranorin@SPION treated group were significantly lower than those in the control group (Supplementary data Figure S3C). The gene discussed is PECAM1; the disease is neoplasm.